3 months to expiry Ghana · FDA Ghana

MENTHOX CHILDREN'S COUGH SYRUP

SQUILL VINEGAR+GLYCERINE BP+CITRIC ACID

FDA/SD.05-05262 SYRUP 1.7%w/v+9.6%w/v+0.81%w/v alimentary tract and metabolism

What it does

Citric acid is a natural substance often used to help with digestion and to support urinary health.

Commonly used for: urinary tract infections (UTIs), kidney stones, digestive issues

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.05-05262
Registration date
2021-07-30
Expiry date
2026-08-01
Status
3 months to expiry
Active ingredient
SQUILL VINEGAR+GLYCERINE BP+CITRIC ACID
Dosage form
SYRUP
Strength
1.7%w/v+9.6%w/v+0.81%w/v
Pack size
-
Therapeutic class
-
ATC class (WHO)
A06AG - Enemas
RxNorm RxCUI
4910
Manufacturer / MAH
Kinapharma
Country of origin
-
Manufacturer location
Accra, Ghana

Source: Food and Drugs Authority · fetched 2026-04-18 08:33:02 · updated 2026-07-31 04:00:12

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About citric

Citric acid is a natural substance often used to help with digestion and to support urinary health.

What it treats

  • urinary tract infections (UTIs)
  • kidney stones
  • digestive issues

How it works

Citric acid helps to increase the acidity of urine, which can help to prevent the formation of certain types of kidney stones and may aid digestion.

Who it's for

Citric acid is suitable for adults and children who may need help with urinary health or digestion.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About glycerine

Glycerine is a substance that helps to relieve constipation by drawing water into the bowel, making it easier to pass stools.

What it treats

  • constipation
  • bowel preparation before medical procedures

How it works

Glycerine works by attracting water to the intestines, which softens the stool and stimulates bowel movements.

Who it's for

Glycerine is suitable for adults and children who need help with constipation.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About squill

Squill is a natural remedy that is used to help with certain heart and respiratory conditions.

What it treats

  • heart failure
  • congestive heart failure
  • difficulty breathing

How it works

Squill helps improve heart function and can aid in breathing by promoting the elimination of excess fluid from the body.

Who it's for

Adults experiencing heart problems or respiratory issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About vinegar

Vinegar is a common kitchen ingredient often used for cooking and preserving food. It may also have health benefits.

What it treats

  • sore throat
  • skin conditions
  • digestive issues

How it works

Vinegar may help by balancing pH levels and supporting digestion.

Who it's for

Vinegar can be used by most people, but those with certain health conditions should be cautious.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: citric

BNF-referenced

Citric acid, a key intermediate in the citric acid cycle, is a weak organic acid with the molecular formula C10H18O. It is commonly found in citrus fruits and is widely used in the food and pharmaceutical industries for its preservative and flavoring properties. Citric acid is also utilized in various formulations for its ability to enhance solubility and stability of active ingredients.

Indications

  • Acidulant in food and beverages
  • Preservative in pharmaceutical formulations
  • pH adjuster in various chemical preparations

Dosage

Children: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Adults: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Mechanism of action

Citric acid acts by chelating metal ions, which can enhance the solubility of certain compounds and improve their bioavailability. It also contributes to the acidity of the environment, which can influence enzymatic activity and metabolic pathways, particularly in the degradation of citronellol.

Pharmacodynamics

Citric acid exhibits mild pharmacological effects primarily attributed to its role in metabolic processes. It aids in the regulation of pH levels, which can impact enzymatic reactions and biochemical pathways. The acid's chelating properties may help to reduce the toxicity of certain metal ions in biological systems.

Pharmacokinetics

Citric acid is rapidly absorbed after oral administration and is metabolized in the liver. It undergoes conversion to various metabolites in the citric acid cycle, contributing to energy production. The elimination primarily occurs through urine, with minimal accumulation in the body.

Pregnancy

Citric acid is generally regarded as safe during pregnancy when used in food amounts. However, consult a healthcare provider for advice on medicinal use.

Breast-feeding

Citric acid is considered safe during breastfeeding when consumed in food amounts. For medicinal use, consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: glycerine

BNF-referenced

Glycerine, also known as glycerol, is a colorless, odorless, viscous liquid classified primarily as an osmotic laxative. It is used to relieve constipation and to decrease intraocular pressure in certain medical conditions. Glycerine works by drawing water into the intestines or the eye, facilitating evacuation or reducing pressure respectively. It is commonly available in suppository form for rectal administration and is effective within 15 to 30 minutes.

Indications

  • Constipation
  • Decreased intraocular pressure

Dosage

Children: For children, refer to the BNF for Children for appropriate glycerin dosing guidelines.

Adults: For constipation, glycerin can be administered rectally as a suppository. Follow specific product guidelines for dosage.

Mechanism of action

When administered rectally, glycerine exerts a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexively stimulating evacuation. Additionally, glycerine decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, leading to fluid movement out of the aqueous and vitreous humors into the bloodstream.

Pharmacodynamics

Glycerine is commonly classified as an osmotic laxative but may also exert local irritant effects, lubricating, and fecal softening actions. Its onset of action typically occurs within 15 to 30 minutes when used as a suppository.

Pharmacokinetics

Glycerine is readily absorbed and metabolized in the body. It undergoes glycerol metabolism pathways, contributing to various biochemical processes including phospholipid biosynthesis. The pharmacokinetic profile of glycerine indicates a rapid onset of action due to its osmotic properties.

Adverse effects

  • Abdominal cramps
  • Diarrhea
  • Nausea
  • Vomiting
  • Electrolyte imbalance

Precautions

  • Use with caution in patients with renal impairment
  • May cause dehydration if used excessively
  • Monitor for electrolyte disturbances in prolonged use

Pregnancy

Glycerin is generally considered safe to use during pregnancy for indicated conditions. Always consult a healthcare provider before use.

Breast-feeding

Glycerin is unlikely to be harmful in breastfeeding mothers. Consult a healthcare provider for specific guidance.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Suppositories
  • Oral solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: squill

BNF-referenced

Squill is an herbal remedy derived from the bulbs of the Urginea (or Scilla) species, particularly Urginea maritima. Traditionally, it has been used for its cardiotonic and diuretic properties. The active compounds in squill are glycosides, which are believed to exert their effects primarily on the heart and kidneys. Due to its potent effects, squill should be used with caution and under medical supervision.

Indications

  • Heart failure
  • Edema
  • Hypertension
  • Congestive heart failure

Dosage

Children: Refer to the BNF for Children for specific dosage information regarding squill in paediatric patients.

Adults: Refer to the BNF for specific dosage information regarding squill in adults.

Mechanism of action

Squill contains cardiac glycosides, which inhibit the Na+/K+ ATPase enzyme. This inhibition leads to an increase in intracellular sodium levels, which causes an increase in intracellular calcium levels via the sodium-calcium exchanger. This results in enhanced myocardial contractility (positive inotropic effect) and a reduction in heart rate (negative chronotropic effect). Additionally, squill promotes diuresis by increasing renal blood flow and glomerular filtration rate.

Pharmacodynamics

The positive inotropic effect of squill enhances cardiac output and is useful in the management of certain heart conditions. The diuretic effect aids in fluid management, making it beneficial for patients with heart failure or edema. However, the therapeutic window is narrow, and toxicity can occur with overdose, leading to arrhythmias and gastrointestinal disturbances.

Pharmacokinetics

The pharmacokinetics of squill have not been extensively studied. However, it is generally understood that the active glycosides are absorbed in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours after ingestion. The elimination half-life is variable and depends on the specific glycoside. The metabolites are primarily excreted via the kidneys.

Pregnancy

The safety of squill during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

It is not known whether squill is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: vinegar

BNF-referenced

Vinegar, primarily consisting of acetic acid (C2H4O2), is a widely used condiment and preservative. It is produced through the fermentation of ethanol by acetic acid bacteria. In addition to its culinary uses, vinegar has been studied for its potential health benefits, including antimicrobial properties and effects on glucose metabolism. However, its clinical applications are limited and primarily focused on dietary uses.

Indications

  • Culinary uses
  • Food preservation
  • Potential antimicrobial applications
  • Dietary supplement for blood glucose management

Dosage

Children: Refer to specific dietary guidelines or culinary applications as there is no standardized clinical dosing for vinegar.

Adults: Refer to specific dietary guidelines or culinary applications as there is no standardized clinical dosing for vinegar.

Mechanism of action

Acetic acid induces apoptosis in yeast cells through mechanisms that involve alterations in the target of rapamycin (TOR) pathway. This pathway is crucial for various cellular processes, including amino-acid biosynthesis, carbohydrate metabolism, and stress response. The apoptotic signaling triggered by acetic acid involves the general amino-acid control (GAAC) system, indicating that acetic acid affects protein turnover and cell cycle regulation by modulating specific protein levels and pathways.

Pharmacodynamics

The pharmacodynamics of acetic acid suggest that it influences various metabolic pathways, particularly those related to amino-acid biosynthesis and stress responses. Its ability to induce apoptosis in yeast indicates a potential for modulating cell growth and death, although the clinical significance of these effects in humans remains unclear. It may also exhibit antimicrobial activity, contributing to its use as a preservative.

Pharmacokinetics

The pharmacokinetics of acetic acid are not extensively documented in the context of clinical use. However, when ingested, acetic acid is rapidly absorbed in the gastrointestinal tract. It is metabolized primarily in the liver and may influence the metabolism of carbohydrates and fats. Due to its acidic nature, acetic acid can affect gastric pH and subsequently influence the absorption of other substances.

Pregnancy

There is insufficient data on the use of vinegar during pregnancy. Caution is advised.

Breast-feeding

Limited data exists on the effects of vinegar during breastfeeding. Consult a healthcare professional before use.

Storage

Store in a cool, dark place, tightly sealed to maintain quality.

Formulations

  • Vinegar (acetic acid solution)
  • Apple cider vinegar
  • White vinegar
  • Balsamic vinegar

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: citric

PubChem CID 7794

Molecular formula: C10H18O

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: glycerine

PubChem CID 753

Molecular formula: C3H8O3

Mechanism of action

When administered rectally, glycerin exerts a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexively stimulating evacuation. Glycerin decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, causing fluid to move out of the aqueous and vitreous humors into the bloodstream. Glycerin (glycerol) and sorbitol are hyperosmotic laxatives. When administered rectally, glycerin and sorbitol exert a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexly stimulating evacuation. The extent to which the simple physical distention of the rectum and the hygroscopic and/or local irritant actions are responsible for the laxative effects of some of these drugs is not known. Only extremely high oral doses of sorbitol (25 g daily) or glycerin exert laxative action. /Glycerin/ decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, causing fluid to move out of the aqueous and vitreous humors into the bloodstream. The physicochemical effects of a series of alkanols, alkanediols and glycerol on erythrocyte shape and hemolysis at 4 and 20 degrees C were examined. We calculated the dielectric constant of the incubation medium, Ds, and the dielectric constant of the erythrocyte membrane Dm in the presence of organic solutes. The ratio Ds/Dm = -38.48 at 20 degrees C defines the normal biconcave shape in a medium without hemolytic agents. A decrease in Ds/Dm favors externalization or internalization with consequent hemolysis. Alkanols and alkanediols convert biconcave erythrocytes into echinocytes, which is accompanied by an increase in the projected surface area. Glycerol converts biconcave erythrocytes into stomatocytes, which was accompanied by a marginal decrease in the projected surface area. Progressive externalization in alkanols and alkanediols or internalization in glycerol resulted in a decrease in the projected surface area and the formation of smooth spheres. The degree of shape change induced was related to the degree of hemolysis and the ratio Ds/Dm. A decrease in temperature reduced both the degree of shape change and hemolysis. .../Thus/ physicochemical toxicity may be a result of a temperature dependent hydrophobic interaction between the organic solutes and the membrane and is best interpreted by the ability of the solutes to change Ds and Dm.

Pharmacodynamics

Glycerin is commonly classified as an osmotic laxative but may act additionally or alternatively through its local irritant effects; it may also have lubricating and fecal softening actions. Glycerin suppositories usually work within 15 to 30 minutes.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: squill

PubChem CID 441871

Molecular formula: C32H44O12

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: vinegar

PubChem CID 176

Molecular formula: C2H4O2

Mechanism of action

Although acetic acid has been shown to induce apoptosis in yeast, the exact apoptotic mechanisms remain unknown. Here, /the study examined/ the effects of acetic acid treatment on yeast cells by 2-DE, revealing alterations in the levels of proteins directly or indirectly linked with the target of rapamycin (TOR) pathway: amino-acid biosynthesis, transcription/translation machinery, carbohydrate metabolism, nucleotide biosynthesis, stress response, protein turnover and cell cycle. The increased levels of proteins involved in amino-acid biosynthesis presented a counteracting response to a severe intracellular amino-acid starvation induced by acetic acid. Deletion of GCN4 and GCN2 encoding key players of general amino-acid control (GAAC) system caused a higher resistance to acetic acid indicating an involvement of Gcn4p/Gcn2p in the apoptotic signaling. Involvement of the TOR pathway in acetic acid-induced apoptosis was also reflected by the higher survival rates associated to a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-negative phenotype and lower reactive oxygen species levels of Deltator1 cells. In addition, deletion mutants for several downstream mediators of the TOR pathway revealed that apoptotic signaling involves the phosphatases Pph21p and Pph22p but not Sit4p. Altogether, /these/ results indicate that GAAC and TOR pathways (Tor1p) are involved in the signaling of acetic acid-induced apoptosis. Acetic acid was found to have actions on urinary bladder smooth muscle in /the/ routine ion channel screening assays. Numerous studies have examined the mechanisms of bladder irritation by acetic acid; however, the direct effect of acetic acid on ion channels in detrusor smooth muscle cells has not been evaluated. /The study/ used whole-cell patch-clamp techniques to examine the effect of acetic acid on large-conductance Ca2+-activated K+ channels (BKCa) from guinea pig detrusor smooth muscle cells and CHO cells expressing recombinant human BKCaalphabeta1 (CHO BKCaalphabeta1) and human BKCaalpha (CHO BKCaalpha). Acetic acid activated BKCa currents in a concentration-dependent (0.01% to 0.05% v/v) manner in all the cell systems studied. Acetic acid (0.05%) increased BKCa current at +30 mV by 2764 +/- 918% (n=8) in guinea pig detrusor smooth muscle cells. Acetic acid (0.03%) shifted the V1/2 of conductance-voltage curve by 64 +/- 14 (n=5), 128 +/- 14 (n=5), and 126 +/- 12 mV (n=4) in CHO BKCaalpha, CHO BKCaalphabeta1 and detrusor smooth muscle cells, respectively. This effect of acetic acid was found to be independent of pH and was also not produced by its salt form, sodium acetate. Automated patch-clamp experiments also showed similar activation of CHO BKCaalphabeta1 by acetic acid. In conclusion, acetic acid directly activates BKCa channels in detrusor smooth muscle cells. This novel study necessitates caution while interpreting the results from acetic acid bladder irritation model. /It was/ previously shown that acetic acid activates a mitochondria-dependent death process in Saccharomyces cerevisiae and that the ADP/ATP carrier (AAC) is required for mitochondrial outer membrane permeabilization and cytochrome c release. Mitochondrial fragmentation and degradation have also been shown in response to this death stimulus. Herein, /the study/ show that autophagy is not active in cells undergoing acetic acid-induced apoptosis and is therefore not responsible for mitochondrial degradation. Furthermore, /the study/ found that the vacuolar protease Pep4p and the AAC proteins have a role in mitochondrial degradation using yeast genetic approaches. Depletion and overexpression of Pep4p, an orthologue of human cathepsin D, delays and enhances mitochondrial degradation respectively. Moreover, Pep4p is released from the vacuole into the cytosol in response to acetic acid treatment. AAC-deleted cells also show a decrease in mitochondrial degradation in response to acetic acid and are not defective in Pep4p

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.